Epertinib
目录号: A13777
EGFR/HER2/HER4 抑制剂
Epertinib 是一种强效的、口服的、可逆的、选择性的酪氨酸激酶抑制剂,针对 EGFR、HER2 和 HER4,其半抑制浓度(IC50s)分别为 1.48 nM、7.15 nM 和 2.49 nM。Epertinib 显示出强大的抗肿瘤活性。
Discription | Epertinib is a potent, oral, reversible, and selective tyrosine kinase inhibitor of EGFR, HER2 and HER4, with IC50s of 1.48 nM, 7.15 nM and 2.49 nM, respectively. Epertinib shows potent antitumor activity. | ||
---|---|---|---|
Targets |
|
目录号 | A13777 |
---|---|
分子式 | C30H27ClFN5O3 |
分子量 | 560.02 |
CAS号 | 908305-13-5 |
SMILES | CC#C/C(C1=CC2=C(NC3=CC=C(OCC4=CC=CC(F)=C4)C(Cl)=C3)N=CN=C2C=C1)=N\OC[C@@H]5NCCOC5 |
其他名称 | S-22611, S22611, S 22611 |
储存条件 | Store lyophilized at -20ºC, keep desiccated. |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2